SORBENT THERAPEUTICS INC

Profile

Company Names

SORBENT THERAPEUTICS INC

Addresses

710 LAKEWAY DRIVE, SUITE 290, SUNNYVALE, CA 94085

710 LAKEWAY DRIVE, SUITE 290, SUNNYVALE, CA 94085

750 EAST BUNKER COURT, SUITE 900, VERNON HILLS, IL 60061

Phone Numbers

408-738-8240
408-857-5248
847-890-1130

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2005

State Incorporated:

DELAWARE

Total Amount Raised:

$58,604,127.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2014-04-30 
$6,500,000.00 
$15,000,000.00 
$8,500,000.00 
Equity 
4
2012-07-27 
$18,056,217.00 
$24,056,217.00 
$6,000,000.00 
Equity 
3
2012-05-31 
$6,000,000.00 
$6,000,000.00 
$0.00 
Debt 
2
2011-06-14 
$11,234,761.00 
$36,000,000.00 
$24,765,239.00 
Equity 
1
2010-06-30 
$16,813,149.00 
$21,813,149.00 
$5,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DETLEF 
 
ALBRECHT 
EXECUTIVE OFFICER, DIRECTOR
LINDA 
 
ARA 
EXECUTIVE OFFICER
LINDA 
 
DE YOUNG 
EXECUTIVE OFFICER
HOWARD 
C. 
DITTRICH 
EXECUTIVE OFFICER
MARCUS 
 
GOEBEL 
DIRECTOR
DONALD 
 
JOSEPH 
EXECUTIVE OFFICER, DIRECTOR
JASON 
 
LEVIN 
EXECUTIVE OFFICER
THOMAS 
P. 
O-NEIL 
EXECUTIVE OFFICER
WILLIAM 
 
RAJSKI 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-04-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-27 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2012-05-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#